Alessandro Introna, Eustachio D’Errico, Boris Modugno, Antonio Scarafino, Angela Fraddosio, Eugenio Distaso, Irene Tempesta, Antonella Mastronardi, Isabella Laura Simone Neurology Unit, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari “Aldo Moro,” Bari, Italy Objective: Riluzole is the first drug approved to treat amyotrophic lateral sclerosis (ALS). Recently, an oral suspension (OS) of riluzole was made available. Thus, the aim of our study was to evaluate the adherence to 2 formulations of riluzole in patients with ALS.Patients and methods: We enrolled 45 consecutive patients with ALS. At disease diagnosis, riluzole was prescribed in 2 different formulations depending on the seve...
Amyotrophic lateral sclerosis (ALS) is a devastating and fatal neurodegenerative disease of adults w...
International audienceIntroduction: To date, riluzole and edaravone are the only two drugs that have...
Riluzole is the only treatment known to improve survival in patients with Amyotrophic Lateral Sclero...
Objective: Riluzole is the first drug approved to treat amyotrophic lateral sclerosis (ALS). Recentl...
Abstract The Patient Preference Survey aims to understand unmet needs related to riluzole management...
Purpose: Riluzole is indicated to prolong life or delay the institution of mechanical ventilation in...
Background: This analysis describes the use of riluzole in amyotrophic lateral sclerosis (ALS) indiv...
Ana Paróla,1 Fátima da Silva Mousinho de Palhares Falcão,1,2 Helena Farinha,1 A...
Riluzole is to date the only treatment that prolongs amyotrophic lateral sclerosis (ALS) survival. H...
Objectives: To investigate the effectiveness of riluzole in a long-term follow-up of cohort with spo...
This retrospective study aimed to investigate the clinical features associated with deteriorated swa...
OBJECTIVE: In this prospective population-based registry study on ALS survival, we investigated the...
International audienceAmyotrophic Lateral Sclerosis (ALS) is a fatal adult-onset neurodegenerative d...
Riluzole exerts a dose-dependent effect on survival of patients with ALS and, although serum levels ...
The prognostic role of riluzole, enteral nutrition (EN), non-invasive ventilation (NIV) and interdis...
Amyotrophic lateral sclerosis (ALS) is a devastating and fatal neurodegenerative disease of adults w...
International audienceIntroduction: To date, riluzole and edaravone are the only two drugs that have...
Riluzole is the only treatment known to improve survival in patients with Amyotrophic Lateral Sclero...
Objective: Riluzole is the first drug approved to treat amyotrophic lateral sclerosis (ALS). Recentl...
Abstract The Patient Preference Survey aims to understand unmet needs related to riluzole management...
Purpose: Riluzole is indicated to prolong life or delay the institution of mechanical ventilation in...
Background: This analysis describes the use of riluzole in amyotrophic lateral sclerosis (ALS) indiv...
Ana Paróla,1 Fátima da Silva Mousinho de Palhares Falcão,1,2 Helena Farinha,1 A...
Riluzole is to date the only treatment that prolongs amyotrophic lateral sclerosis (ALS) survival. H...
Objectives: To investigate the effectiveness of riluzole in a long-term follow-up of cohort with spo...
This retrospective study aimed to investigate the clinical features associated with deteriorated swa...
OBJECTIVE: In this prospective population-based registry study on ALS survival, we investigated the...
International audienceAmyotrophic Lateral Sclerosis (ALS) is a fatal adult-onset neurodegenerative d...
Riluzole exerts a dose-dependent effect on survival of patients with ALS and, although serum levels ...
The prognostic role of riluzole, enteral nutrition (EN), non-invasive ventilation (NIV) and interdis...
Amyotrophic lateral sclerosis (ALS) is a devastating and fatal neurodegenerative disease of adults w...
International audienceIntroduction: To date, riluzole and edaravone are the only two drugs that have...
Riluzole is the only treatment known to improve survival in patients with Amyotrophic Lateral Sclero...